[Federal Register Volume 85, Number 238 (Thursday, December 10, 2020)]
[Notices]
[Page 79491]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-27123]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2020-N-2227]


Food and Drug Administration Fiscal Year 2020 Performance Review 
Board

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the names 
of the members who will serve on its fiscal year (FY) 2020 Performance 
Review Board (PRB). The purpose of the PRB is to provide fair and 
impartial review of Senior Executive Service (SES), Senior 
Professional, 21st Century Cures Act, and Title 42(f) (SES Equivalents) 
performance appraisals, bonus recommendations, and pay adjustments.

DATES: Approved October 1, 2020.

FOR FURTHER INFORMATION CONTACT: Abu Sesay, Office of Human Capital 
Management (OHCM), Three White Flint North, 02C47, 11601 Landsdown St., 
North Bethesda, MD 20852, Office Number: 240-402-0440 (not a toll-free 
number).

SUPPLEMENTARY INFORMATION: This action is being taken pursuant to 5 
U.S.C. 4314(c)(4), which requires that members of performance review 
boards be appointed in a manner to ensure consistency, stability, and 
objectivity in performance appraisals and requires that notice of the 
appointment of an individual to serve as a member be published in the 
Federal Register.
    The following persons will serve on the FDA FY 2020 Performance 
Review Board, which oversees the evaluation of performance appraisals 
of FDA's Senior Executives and Equivalents:

 James Sigg, PRB Chair
 Tania Tse, PRB Officiator
 Glenda Barfell
 Janelle Barth
 Vincent Bunning
 Mary Beth Clarke
 Elizabeth Dickinson
 Tracey Forfa
 Denise Huttenlocker
 Diane Maloney
 William Tootle

    Dated: December 4, 2020.
Lauren K. Roth,
Acting Principal Associate Commissioner for Policy.
[FR Doc. 2020-27123 Filed 12-9-20; 8:45 am]
BILLING CODE 4164-01-P